NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); […]

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); […]

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); […]

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GigaCloud Technology Inc. (NASDAQ: GCT): (i) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); […]

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds investors of the common stock of Axsome Therapeutics, Inc. (“Axsome”) (NASDAQ: AXSM) of the reopening of the lead plaintiff appointment process in a class action lawsuit against Axsome and certain of its officers. The Class Action, […]

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Barclays PLC (NYSE: BCS) (OTC: BCLYF) between July 22, 2019 and October 12, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the […]